Combination Therapy of Oral Fluoropyrimidine Anticancer Drug S-1 and Interferon Alpha for HCC Patients with Extrahepatic Metastases

Publisher： Karger

E-ISSN： 1423-0232|75|1-2|8-16

ISSN： 0030-2414

Source： Oncology, Vol.75, Iss.1-2, 2008-08, pp. : 8-16

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Combination Therapy with S-1 and Pegylated Interferon Alpha for Advanced Hepatocellular Carcinoma

By  

Oncology, Vol. 75, Iss. 1, 2008-12 ,pp. : 106-113

Karger

Access to resources Recommend Favorite

Intra‐arterial 5‐fluorouracil/interferon combination therapy for hepatocellular carcinoma with portal vein tumor thrombosis and extrahepatic metastases

By  

JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, Vol. 25, Iss. 6, 2010-06 ,pp. : 1117-1122

John Wiley & Sons Inc

Access to resources Recommend Favorite

Incidence of Depression in Patients with Chronic Hepatitis C Receiving Combination Therapy of Pegylated Interferon-Alpha and Ribavirin

By  

Psychotherapy and Psychosomatics, Vol. 83, Iss. 5, 2014-08 ,pp. : 308-309

Karger

Access to resources Recommend Favorite

Panitumumab in combination with infusional oxaliplatin and oral capecitabine for conversion therapy in patients with colon cancer and advanced liver metastases

By  

CANCER, Vol. 119, Iss. 19, 2013-10 ,pp. : 3429-3435

John Wiley & Sons Inc

Access to resources Recommend Favorite

Cutaneous S100‐negative, CD1a‐positive histiocytosis successfully treated with combination therapy of oral methotrexate and corticosteroid

By  

THE JOURNAL OF DERMATOLOGY, Vol. 42, Iss. 10, 2015-10 ,pp. : 999-1001

John Wiley & Sons Inc

Access to resources Recommend Favorite